Please wait while the formulary information is being retrieved.
Drug overview for REDNESS LUBRICANT EYE DROPS (naphazoline hcl/polyethylene glycol 300):
Generic name: NAPHAZOLINE HCL/POLYETHYLENE GLYCOL 300 (nah-FAZZ-oh-leen)
Drug class: Ophthalmic Decongestants
Therapeutic class: Ophthalmic Agents
Naphazoline hydrochloride, an imidazoline-derivative sympathomimetic amine, is a vasoconstrictor.
No enhanced Uses information available for this drug.
Generic name: NAPHAZOLINE HCL/POLYETHYLENE GLYCOL 300 (nah-FAZZ-oh-leen)
Drug class: Ophthalmic Decongestants
Therapeutic class: Ophthalmic Agents
Naphazoline hydrochloride, an imidazoline-derivative sympathomimetic amine, is a vasoconstrictor.
No enhanced Uses information available for this drug.
DRUG IMAGES
No Image Available
The following indications for REDNESS LUBRICANT EYE DROPS (naphazoline hcl/polyethylene glycol 300) have been approved by the FDA:
Indications:
Dry eye
Ocular irritation
Ocular redness
Professional Synonyms:
Eye dryness
Eye redness
Ocular erythema
Ophthalmic irritation
Xerophthalmia
Indications:
Dry eye
Ocular irritation
Ocular redness
Professional Synonyms:
Eye dryness
Eye redness
Ocular erythema
Ophthalmic irritation
Xerophthalmia
The following dosing information is available for REDNESS LUBRICANT EYE DROPS (naphazoline hcl/polyethylene glycol 300):
No enhanced Dosing information available for this drug.
Ophthalmic solutions of naphazoline hydrochloride are applied topically to the conjunctiva. Care must be taken to avoid contamination of the dropper tip. Some manufacturers recommend that contact lenses be removed before administration of ophthalmic solutions containing naphazoline.
Naphazoline hydrochloride nasal solutions are applied topically to the nasal mucosa. To minimize the risk of spreading infection, containers should not be used by more than one person.
Naphazoline hydrochloride nasal solutions are applied topically to the nasal mucosa. To minimize the risk of spreading infection, containers should not be used by more than one person.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for REDNESS LUBRICANT EYE DROPS (naphazoline hcl/polyethylene glycol 300):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for REDNESS LUBRICANT EYE DROPS (naphazoline hcl/polyethylene glycol 300):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 1 contraindications.
Absolute contraindication.
| Contraindication List |
|---|
| Angle-closure glaucoma |
There are 0 severe contraindications.
There are 5 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| Diabetes mellitus |
| Hypertension |
| Hyperthyroidism |
| Ocular infection |
| Ocular injury |
The following adverse reaction information is available for REDNESS LUBRICANT EYE DROPS (naphazoline hcl/polyethylene glycol 300):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 5 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. | None. |
| Rare/Very Rare |
|---|
|
Dizziness Hyperhidrosis Hypertension Ocular hypertension Punctate keratitis |
There are 10 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. |
Blurred vision Mydriasis Ocular irritation |
| Rare/Very Rare |
|---|
|
Drowsy General weakness Headache disorder Hyperglycemia Nausea Nervousness Photophobia |
The following precautions are available for REDNESS LUBRICANT EYE DROPS (naphazoline hcl/polyethylene glycol 300):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
Animal studies have not been conducted with naphazoline hydrochloride, and it is not known whether the drug can cause fetal harm when administered to a pregnant woman. Therefore, naphazoline hydrochloride should be used during pregnancy only when clearly needed.
It is not known whether naphazoline hydrochloride is distributed into milk. Because many drugs are distributed into milk, caution should be exercised when this drug is administered to a breast-feeding woman.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for REDNESS LUBRICANT EYE DROPS (naphazoline hcl/polyethylene glycol 300):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for REDNESS LUBRICANT EYE DROPS (naphazoline hcl/polyethylene glycol 300)'s list of indications:
| Dry eye | |
| H04.12 | Dry eye syndrome |
| H04.121 | Dry eye syndrome of right lacrimal gland |
| H04.122 | Dry eye syndrome of left lacrimal gland |
| H04.123 | Dry eye syndrome of bilateral lacrimal glands |
| H04.129 | Dry eye syndrome of unspecified lacrimal gland |
| H11.14 | Conjunctival xerosis, unspecified |
| H11.141 | Conjunctival xerosis, unspecified, right eye |
| H11.142 | Conjunctival xerosis, unspecified, left eye |
| H11.143 | Conjunctival xerosis, unspecified, bilateral |
| H11.149 | Conjunctival xerosis, unspecified, unspecified eye |
| H16.221 | Keratoconjunctivitis sicca, not specified as sjogren's, right eye |
| H16.222 | Keratoconjunctivitis sicca, not specified as sjogren's, left eye |
| H16.223 | Keratoconjunctivitis sicca, not specified as sjogren's, bilateral |
| H16.229 | Keratoconjunctivitis sicca, not specified as sjogren's, unspecified eye |
| Ocular irritation | |
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
| Ocular redness | |
| H57.8 | Other specified disorders of eye and adnexa |
| H57.89 | Other specified disorders of eye and adnexa |
Formulary Reference Tool